Promisingly, by inhibiting LDHA, acting on the NSG1/TGF-β axis, significant changes were observed which manifested as a notable decrease in the invasion and migratory abilities of ESCC cells. This evidence concerns the gene NSG1 and esophageal squamous cell carcinoma.